What's new?
Latest News
Keep up with the latest news from Research breakthroughs to Company news
Stay Connected
Explore Our Latest Insights on LinkedIn
News
Find All the Current News Here as We Continue Our Journey in Advancing Bacteriophage Solutions
…
Following the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee) recent meeting in Brussels, Proteon Pharmaceuticals is pleased to share a significant development…
…
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a…
…
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains…
…
We are excited to announce that our bacteriophage-based technology has been granted patent protection by the Polish Patent Office. The invention, “Bacteriophage strains and their…
…
Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella…
…
We are pleased to share the significant progress Proteon Pharmaceuticals made in 2024. Our company strengthened its market position, advanced its research initiatives, and expanded…
…
Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based…
…
Proteon Pharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The…
…
At Proteon Pharmaceuticals S.A., we’re dedicated to supporting the growth of future scientists and professionals. This summer, we offered the internships to six students, eager…
…
Proteon Pharmaceuticals is thrilled to announce the obtaining of a new European patent for our pioneering technology: “Method and Kit for Detection of Extraintestinal E.…
…
We are excited to introduce our new video series “Inside Innovation: Micro Talks with the CEO”, launching today on our social media channels. In this…
…
Proteon Pharmaceuticals is glad to announce the latest findings from our recent studies: “A Rapid and Inexpensive PCR Test for Mastitis Diagnosis Based on NGS…
…
Our dedicated Research and Development Team is thrilled to announce the results of one of the recently conducted breakthrough studies: “Novel multiplex-PCR test for Escherichia…
…
In the recent report prepared by the Executive Forecast, Professor Jarosław Dastych shared his passion for bacteriophage technology and threw light upon how it can…
…
Proteon Pharmaceuticals S.A. is pleased to announce the launch of their latest manufacturing facility in India. This 700-metre square factory is designed with cutting-edge zones…
…
Proteon Pharmaceuticals S.A. is delighted to announce the appointment of Márcio Caparroz as our new Chief Commercial Officer (CCO), starting 1st March 2024. Márcio brings…
…
Now as 2024 unfolds, let’s take a moment to reflect on the key events and milestones of 2023 with a comprehensive summary. In the…
…
In the year’s closing interview with Feedinfo, Justyna Andrysiak, Chief Product and Technology Officer at Proteon Pharmaceuticals, sheds light on the recent breakthroughs and the…
…
In an exclusive interview with Hind Poultry, Professor Jarosław Dastych, the Founder and CEO of Proteon Pharmaceuticals, shares the company’s pioneering work in the field…
…
In a recent interview with The Poultry Site, Professor Jarosław Dastych, the Founder and CEO of Proteon Pharmaceuticals, shared insights into the company’s pioneering efforts…
…
In an interview conducted by the Feedinfo with DrEwelina Wójcik, Chief Scientific Officer at Proteon Pharmaceuticals, the latter outlined the core mission of the CBB…
…
Łódź, 21 July 2023 – Proteon Pharmaceuticals opens the Center for Bacteriophage Biotechnology in Łódź Proteon Pharmaceuticals is delighted to announce the inauguration of its groundbreaking…
…
Proteon Pharmaceuticals was featured by CBS News under the Global Thought Leaders campaign, highlighting innovation at its core through biotechnology and dedication to improving animal…
…
Łódź, 9 May 2022 – Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals today. Commissioner Wojciechowski’s visit to Proteon Pharmaceuticals is to get better acquainted…
…
Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within…
…
PROTEON CONTINUES DIALOGUE WITH EU COMMISSION TO SECURE EARLY AUTHORIZATION In its first-ever evaluation of a bacteriophage feed additive, EFSA (European Food Safety Authority) concluded…
…
The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish…
…
In 2008, a superbug caught from a New Delhi hospital claimed the life of a Swedish patient. British scientists who found this “superbug” in New…
…
In response to the fight against coronavirus, Proteon Pharmaceuticals has joined the effort to create a new SARS-CoV-2 Coronavirus Detection Center in Lodz, Poland to…
…
A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain. In an attempt to find a…
…
Proteon Pharamceuticals, a global leader in the development and commercialization of bacteriophages for industrial use in poultry farming, is now a member of the U.S.…
…
Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in livestock farming in poultry, dairy…
…
Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu…
…
Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in Boston, USA. He spoke on the topic…
…
Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference in London, UK.. COO and Board Member Matthew Tebeau accepted the…
…
Proteon Pharmaceuticals COO Matthew Tebeau sat down with Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The Poland-based biotech…
…
Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within…
…
Proteon Pharmaceuticals was an invited speaker at the 9th edition of the FIAAP Animal Nutrition conference held on March 27, 2018 in Bangkok, Thailand. This…
…
Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon…
…
Proteon Pharmaceuticals presents its unique product BAFADOR® at the international bacteriophage conference in Tbilisi Proteon Pharmaceuticals participated in the international conference “Centennial Celebration of Bacteriophage…
…
In 2016 Proteon Pharmaceuticals awarded grants from Polish Center for Research & Development for Euro 3.2 m In 2016, Proteon Pharmaceuticals signed the agreements for…